TNDM
Tandem Diabetes Care IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.33B
P/E Ratio
—
EPS
$-3.04
Beta
1.74
52W High
$29.65
52W Low
$9.98
50-Day MA
$21.61
200-Day MA
$17.80
Dividend Yield
—
Profit Margin
-20.20%
Forward P/E
1111.11
PEG Ratio
0.00
About Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $1.01B |
| Gross Profit (TTM) | $546.01M |
| EBITDA | $-60.46M |
| Operating Margin | 2.86% |
| Return on Equity | -97.90% |
| Return on Assets | -5.28% |
| Revenue/Share (TTM) | $15.08 |
| Book Value | $2.27 |
| Price-to-Book | 8.19 |
| Price-to-Sales (TTM) | 1.31 |
| EV/Revenue | 1.403 |
| EV/EBITDA | 345.75 |
| Quarterly Earnings Growth (YoY) | -37.00% |
| Quarterly Revenue Growth (YoY) | 2.70% |
| Shares Outstanding | $68.50M |
| Float | $62.61M |
| % Insiders | 0.69% |
| % Institutions | 112.64% |
Historical Volatility
HV 10-Day
73.38%
HV 20-Day
71.50%
HV 30-Day
65.45%
HV 60-Day
85.16%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($30.76 target)
2
Strong Buy8
Buy14
HoldData last updated: 4/9/2026